Related Experiment Video
Updated: Oct 12, 2026

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides
1Urological Oncology Section, National Cancer Institute, Bethesda, Maryland 20892, USA.
Abstract:
Renal cell carcinoma (RCC) is the most common malignancy in the adult kidney. Because RCC is generally thought to arise from the epithelium of the proximal tubules, the expression of Pax-2, a gene required for renal epithelium development, was examined in primary tumors and tumor-derived cell lines. Immunostaining of frozen sections from the primary tumors indicated Pax-2 expression in the malignant cells but not in the surrounding stroma. In a panel of human RCC-derived cell lines, 73% expressed Pax-2 protein and mRNA. Treatment of RCC cell lines with antisense oligodeoxynucleotides resulted in down-regulation of Pax-2 protein expression and growth inhibition after 3 days in culture. These data indicate that Pax-2 gene function is required for proliferation, as well as differentiation during embryonic development, and suggest a novel therapy for RCC.
Insights
Pax-2 gene expression is common in renal cell carcinoma (RCC) and is crucial for tumor cell proliferation. Inhibiting Pax-2 may offer a novel therapeutic strategy for treating kidney cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Renal cell carcinoma (RCC) is the most prevalent adult kidney malignancy.
- RCC is believed to originate from the proximal tubule epithelium.
- Pax-2 is essential for renal epithelium development.
Purpose of the Study:
- To investigate the expression of Pax-2 in renal cell carcinoma.
- To determine the role of Pax-2 in RCC cell proliferation.
- To explore Pax-2 as a potential therapeutic target for RCC.
Main Methods:
- Immunohistochemical staining of primary tumor samples.
- Analysis of Pax-2 protein and mRNA expression in RCC cell lines.
- Treatment of RCC cell lines with antisense oligodeoxynucleotides.
Main Results:
- Pax-2 was expressed in malignant RCC cells, not in surrounding stroma.
- 73% of human RCC cell lines showed Pax-2 protein and mRNA expression.
- Antisense oligodeoxynucleotides targeting Pax-2 reduced protein levels and inhibited cell growth.
Conclusions:
- Pax-2 gene function is vital for RCC cell proliferation.
- Pax-2 plays a role in both embryonic renal development and RCC progression.
- Targeting Pax-2 presents a potential novel therapeutic approach for renal cell carcinoma.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

